Author | Kelly Valla, PharmD, BCOP

Articles

Practical Dosing Considerations for Venetoclax

September 20, 2019

With FDA-approved indications for both chronic lymphocytic leukemia and acute myeloid leukemia, and continued investigation within multiple disease states, venetoclax has become an exciting oral targeted therapy among oncologists.